CTOs on the Move


 
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nymox.com
  • Heights Plaza 777 Terrace Avenue
    Hasbrouck Heights, NJ USA 07604
  • Phone: 800.936.9669

Executives

Name Title Contact Details

Funding

Nymox raised $16.3M on 04/12/2018

Similar Companies

LifeMed Media, Inc

LifeMed Media, Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Briarwood Manor

Briarwood Manor is a Lockport, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kaberline Healthcare

Kaberline Healthcare is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Polyvue Technologies

Polyvue Technologies is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cancer Expert Now

Cancer Expert Now`s services connect you to distinguished experts to discuss current disease challenges, recent literature, global clinical findings, and even share their research and experience in the context of your specific diagnosis, or patient cases.